Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 2 Study if E coli O157-Repa Conjugate Vaccine in 2-5 Year Old Ch-275023337
Carolinas Medical Center, Charlotte, NC, United States
Search grants from Carolinas Medical Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Preclinical development of a chemopreventive agent, 4-methylumbelliferone(4-MU) HHSN2512015000361 TORFP: 2018-E07 PP: 9/17/18 to 9/16/19
Role of Dendritic Cell Activation in the Pathogenesis of Liver Fibrosis
Microenvironmental control of progenitors in organ dysfunction and repair
Role of Selenium-containing Proteins in Cancer and Development
Muscle Fiber Type Switching in the Lobster Claw
Recently added grants:
Mechanism and Inhibition of Protein Arginine Methylation
Sulfide Oxidation and Signaling
Molecular Basis of Genome Organization and Integrity Using Cryo-EM
Discovery and Development of Organic Reactions Catalyzed by Transition Metals Valuable for Medicinal Chemistry
Mechanism of atypical ubiquitination and deubiquitination by bacterial effectors
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research and Development Contracts (N01)
Project #
N01HD023337-001
Application #
6688576
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Carolinas Medical Center
Department
Type
DUNS #
City
Charlotte
State
NC
Country
United States
Zip Code
28232
Related projects
NIH 2003
N01 HD
Phase 2 Study if E coli O157-Repa Conjugate Vaccine in 2-5 Year Old Ch-275023337
/ Carolinas Medical Center
NIH 2002
N01 HD
Phase 2 Study if E coli O157-Repa Conjugate Vaccine in 2-5 Year Old Ch-275023337
/ Carolinas Medical Center
Comments
Be the first to comment on this grant